Integrated BioPharma (INBP) Q1 net income $1.0M vs $1.2M; revenue up 2.1%

INTEGRATED BIOPHARMA INC

2022-Q2 EPS reported $0.05 revenue$27,345,000

Revenue for quarter ended Dec 31, 2021: $14.6M, up 2.1% YoY from $14.3M.
Operating income fell to $0.7M from $1.2M; net income $1.0M vs $1.2M.
EPS basic unchanged at $0.04; diluted $0.03 vs $0.04.
Six-month revenue down 7.1% to $27.3M; net income $1.5M vs $2.3M.
Co-CEOs attribute 6-month decline to prior year's COVID-related safety stock and demand.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.